Company intelligence / Profile preview

INSCOPER

Ownership: Private
Development stage: Commercial

Overview

INSCOPER provides advanced software solutions for automated image acquisition in fluorescence microscopy. Their technology eliminates software latency to significantly increase acquisition speed, supports integration with major microscope brands and third-party devices, and enables high-content screening as well as live cell imaging. The system has been adopted by research institutions for both fixed sample and live cell analysis[1][2][3].

No clinical results are applicable since this is a research tool/platform company.

Modalities: DeviceSoftware (for fluorescence microscopy and live cell imaging)
Industry: Medical Imaging

Partnerships

Compatible with leading microscope manufacturers such as Leica, Nikon, Olympus, Zeiss[1]

Beyond the preview

Go deeper on INSCOPER.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on INSCOPER.

Explore the full profile